Thursday, October 15, 2026

Alternative Investments

5 articles

TPG Cuts Private Equity Allocation to 45% of AUM, Raises $20B in Credit Strategies

TPG Cuts Private Equity Allocation to 45% of AUM, Raises $20B in Credit Strategies

TPG has reduced private equity exposure from 80% to 45% of assets under management while raising over $20 billion in credit strategies. Third Point launched a new private credit pooled fund as major alternative asset managers pivot toward lending markets. The shift occurs despite continued PE deal activity including Papa Johns bids and the F&G Life Re acquisition.

LM Salvado•
Private Equity Firms Cut Traditional Buyouts to 45% of Assets While Raising $51B in New Capital

Private Equity Firms Cut Traditional Buyouts to 45% of Assets While Raising $51B in New Capital

TPG reduced private equity from 80% to 45% of assets under management since its IPO, raising $51 billion in 2025 across 35 investment products. Major firms are shifting capital into credit, infrastructure, and specialized strategies as middle-market competitors launch pooled funds and target controlling equity stakes with debt positions.

ViaNews Editorial Team (Finance)•
Private Credit Dividends Cut as BlackRock TCP, MidCap Shares Fall 8-9% Amid Crypto Volatility

Private Credit Dividends Cut as BlackRock TCP, MidCap Shares Fall 8-9% Amid Crypto Volatility

Business development companies BlackRock TCP Capital and MidCap Financial cut dividends as shares declined 8-9%, signaling stress in private credit markets. Bitcoin dropped toward $66,000 while industry leaders frame the downturn as a market-clearing opportunity in alternative assets. The dual pressure reflects broader risk repricing across non-traditional investment portfolios.

ViaNews Editorial Team (Finance)•
BDC Dividend Cuts Trigger 8-9% Selloffs as Alternative Investment Stress Spreads

BDC Dividend Cuts Trigger 8-9% Selloffs as Alternative Investment Stress Spreads

BlackRock TCP Capital and MidCap Financial slashed dividends, triggering 8-9% stock declines as business development companies face mounting pressure. The stress signals broader rotation from yield-focused alternative investments toward growth and value plays, with activist investor Jeffrey Eberwein accumulating Star Equity shares at $3.84 versus a claimed $12-15 intrinsic value.

ViaNews Editorial Team (Finance)•
Gold's $4,200 Supercycle: Why Mining Stocks Are the Smart Money's New Tech Trade

Gold's $4,200 Supercycle: Why Mining Stocks Are the Smart Money's New Tech Trade

Gold futures surging past $4,200 per ounce are anchoring a broader rotation into hard assets as Fed rate cut expectations and tech sector weakness prompt institutional investors to revisit precious metals miners. Companies like Fortuna Mining are expanding capacity and strengthening balance sheets, signaling the gold bull cycle still has room to run even as commodities bifurcate sharply between precious and base metals.

ViaNews Editorial Team (Finance)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com